Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,262 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

A Study of 1592U89 in HIV-Infected Patients

NCT00002388

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Evanston Hosp / Clinical Pharmacology Unit Evanston, Illinois, United States
  • Fenway Community Health Ctr / Research Dept Boston, Massachusetts, United States
  • Albany Med College / Albany Med Ctr Hosp Albany, New York, United States
View Trial Details
Active, Not Recruiting

WiseApp for Spanish Speakers Living With HIV

NCT05398185

Conditions
Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +17 more
Locations
  • Columbia University Irving Medical Center New York, United States
  • Clinica de Familia La Romana La Romana, Dominican Republic
View Trial Details
Active, Not Recruiting

Accelerated ART Initiation for PWHIV Who Are Out of Care

NCT06374758

Conditions
ART, Behavior, Blood-Borne Infections, +18 more
Locations
  • University of Missouri-Columbia Columbia, Missouri, United States
  • KC Care Health Center Kansas City, Missouri, United States
  • AIDS Project of the Ozarks Springfield, Missouri, United States
  • NOVUS Health St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants

NCT02938520

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Augusta, Georgia, United States
View all 108 locations
View Trial Details
Active, Not Recruiting

Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

NCT06134362

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • GSK Investigational Site Almagro, Argentina
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Francistown, Botswana
  • GSK Investigational Site Porto Alegre, Brazil
View all 33 locations
View Trial Details
Active, Not Recruiting

DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection

NCT02772003

Conditions
Adenocarcinoma, Blood-Borne Infections, Carcinoma, +25 more
Locations
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Case Western Reserve University Cleveland, Ohio, United States
  • Temple University Hospital Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions